MCMINN RACHEL (Chief Executive Officer) received a stock award from NEUROGENE INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/28/2025ACC: 0001404644-25-000020
DirectorOfficer· Chief Executive Officer
Since Feb 2026
+167.40K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
167.40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+23.90K
Price / share
—
Trade value
—
% of position
1.9%
3/26/2025
1.25M→1.27M
Total
Net shares
+23.90K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/26/2025 | A · Award | +23.90K | — | — | 1.9% | 1.25M | 1.27M |
| Total | +23.90K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (Right to buy)
Direct
Converts to
Common Stock
143.50K shares
Shares
+143.50K
Strike price
16.14
Held after
143.50K
Exercisable
—
3/26/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to buy) Direct | Common Stock143.50K shares | 3/26/2025 | A · Award | +143.50K | 16.14 | — | 143.50K |